Zobrazeno 1 - 10
of 332
pro vyhledávání: '"Vanvoorden, V."'
Autor:
Strober B; Department of Dermatology, Yale University, New Haven, Connecticut; Central Connecticut Dermatology Research, Cromwell, Connecticut. Electronic address: brucestrober30@me.com., Paul C; Toulouse University and INSERM Infinity, Toulouse, France., Blauvelt A; Oregon Medical Research Center, Portland, Oregon., Thaçi D; Insititute and Centre for Inflammation Medicine, University of Lübeck, Lübeck, Germany., Puig L; Hospital de la Santa Creu I Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain., Lebwohl M; Icahn School of Medicine at Mount Sinai, New York, New York., White K; UCB Pharma, Slough, United Kingdom., Vanvoorden V; UCB Pharma, Brussels, Belgium., Deherder D; UCB Pharma, Braine-l'Alleud, Belgium., Gomez NN; Department of Dermatology, UCB Pharma, Monheim, Germany., Eyerich K; Department of Dermatology, Medical Center, University of Freiburg, Freiburg, Germany.
Publikováno v:
Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2023 Sep; Vol. 89 (3), pp. 486-495. Date of Electronic Publication: 2023 May 12.
Autor:
Strober B; Department of Dermatology, Yale University, New Haven, CT, USA.; Central Connecticut Dermatology Research, Cromwell, CT, USA., Tada Y; Department of Dermatology, Teikyo University School of Medicine, Tokyo, Japan., Mrowietz U; Psoriasis Center, Department of Dermatology, University Medical Center Schleswig-Holstein, Campus Kiel, Germany., Lebwohl M; Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Foley P; The University of Melbourne, St Vincent's Hospital Melbourne, Fitzroy, Victoria, Australia.; Probity Medical Research Inc., Skin Health Institute, Carlton, Victoria, Australia., Langley RG; Dalhousie University, Halifax, NS, Canada., Warren RB; Dermatology Centre, Salford Royal NHS Foundation Trust, Manchester NIHR Biomedical Research Centre, The University of Manchester, Manchester, UK., Wang M; UCB Pharma, Morrisville, NC, USA., Vanvoorden V; UCB Pharma, Brussels, Belgium., Szilagyi B; UCB Pharma, Monheim, Germany., Ciaravino V; UCB Pharma, Colombes, France., Paul C; Toulouse University and CHU, Toulouse, France.
Publikováno v:
The British journal of dermatology [Br J Dermatol] 2023 May 24; Vol. 188 (6), pp. 749-759.
Autor:
Asahina A; Department of Dermatology, The Jikei University School of Medicine, Tokyo, Japan., Okubo Y; Department of Dermatology, Tokyo Medical University, Tokyo, Japan., Morita A; Department of Geriatric and Environmental Dermatology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan., Tada Y; Department of Dermatology, Teikyo University School of Medicine, Tokyo, Japan., Igarashi A; Department of Dermatology, NTT Medical Center Tokyo, Tokyo, Japan., Langley RG; Division of Clinical Dermatology and Cutaneous Science, Department of Medicine, Dalhousie University, Halifax, NS, Canada., Deherder D; UCB Pharma, Braine L'alleud, Belgium., Matano M; UCB Pharma, UCB Japan Co., Ltd, 8-17-1 Nishi-Shinjuku, Shinjuku-Ku, Tokyo, 160-0023, Japan. Mizuho.Matano@ucb.com., Vanvoorden V; UCB Pharma, Braine L'alleud, Belgium., Wang M; UCB Pharma, Raleigh, NC, USA., Ohtsuki M; Department of Dermatology, Jichi Medical University, Tochigi, Japan., Nakagawa H; Department of Dermatology, The Jikei University School of Medicine, Tokyo, Japan.
Publikováno v:
Dermatology and therapy [Dermatol Ther (Heidelb)] 2023 Mar; Vol. 13 (3), pp. 751-768. Date of Electronic Publication: 2023 Jan 17.
Autor:
Kokolakis G; Psoriasis Research and Treatment Center, Department of Dermatology, Venereology and Allergology, Charité-Universitätsmedizin Berlin, Berlin, Germany.; Freie Universität Berlin, Berlin, Germany.; Humboldt-Universität zu Berlin, Berlin, Germany., Warren RB; Dermatology Centre, Salford Royal NHS Foundation Trust, Manchester NIHR Biomedical Research Centre, The University of Manchester, Manchester, UK., Strober B; Yale University, New Haven, CT, USA.; Central Connecticut Dermatology Research, Cromwell, CT, USA., Blauvelt A; Oregon Medical Research Center, Portland, OR, USA., Puig L; Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain., Morita A; Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan., Gooderham M; SKiN Centre for Dermatology, Probity Medical Research, Peterborough, ON, Canada.; Queen's University, Kingston, ON, Canada., Körber A; Hautaerzte Rue143, Essen, Germany., Vanvoorden V; UCB Pharma, Brussels, Belgium., Wang M; UCB Pharma, Morrisville, NC, USA., de Cuyper D; UCB Pharma, Brussels, Belgium., Madden C; UCB Pharma, Morrisville, NC, USA., Nunez Gomez N; UCB Pharma, Monheim, Germany., Lebwohl M; Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Publikováno v:
The British journal of dermatology [Br J Dermatol] 2023 Feb 22; Vol. 188 (3), pp. 330-340.
Autor:
Thaçi D; Institute and Comprehensive Center for Inflammation Medicine, University Hospital of Lübeck, Lübeck, Germany., Vender R; Dermatrials Research Inc., Hamilton, ON, Canada., de Rie MA; Department of Dermatology, Amsterdam University Medical Centres, Amsterdam, the Netherlands., Conrad C; Department of Dermatology, Lausanne University Hospital, Switzerland., Pariser DM; Department of Dermatology, Eastern Virginia Medical School, Norfolk, VA, USA.; Virginia Clinical Research, Inc., Norfolk, VA, USA., Strober B; Yale University, New Haven, CT, USA.; Central Connecticut Dermatology Research, Cromwell, CT, USA., Vanvoorden V; UCB Pharma, Brussels, Belgium., Wang M; UCB Pharma, Raleigh, NC, USA., Madden C; UCB Pharma, Raleigh, NC, USA., de Cuyper D; UCB Pharma, Brussels, Belgium., Kimball AB; Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Publikováno v:
The British journal of dermatology [Br J Dermatol] 2023 Jan 23; Vol. 188 (1), pp. 22-31.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Bouznad, A., Warren, R.B., Strober, B., Pinter, A., Blauvelt, A., Sebastian, M., Davis, L., Vanvoorden, V., Wiegratz, S., Gooderham, M.
Publikováno v:
In Annales de Dermatologie et de Vénéréologie - FMC November 2022 2(8) Supplement 1:A339-A339
Publikováno v:
In European Journal of Cancer January 2004 40(2):187-197
Publikováno v:
In European Journal of Cancer 2003 39(3):275-285
Autor:
Reich K; From the Center for Translational Research in Inflammatory Skin Diseases, University Medical Center Hamburg-Eppendorf, Hamburg, Germany (K.R.); the Dermatology Centre, Salford Royal NHS Foundation Trust, Manchester NIHR Biomedical Research Centre, University of Manchester, Manchester, United Kingdom (R.B.W.); the Icahn School of Medicine at Mount Sinai, New York (M.L.); the SKiN Centre for Dermatology, Probity Medical Research, Peterborough, and Queen's University, Kingston, ON (M.G.), and Dalhousie University, Halifax, NS (R.G.L.) - all in Canada; Yale University, New Haven, and Central Connecticut Dermatology Research, Cromwell - both in Connecticut (B.S.); Paul Sabatier University, Toulouse, France (C.P.); UCB Pharma, Brussels (D.D.C., V.V.); UCB Pharma, Raleigh, NC (C.M., C.C., L.P.); and the Oregon Medical Research Center, Portland (A.B.)., Warren RB; From the Center for Translational Research in Inflammatory Skin Diseases, University Medical Center Hamburg-Eppendorf, Hamburg, Germany (K.R.); the Dermatology Centre, Salford Royal NHS Foundation Trust, Manchester NIHR Biomedical Research Centre, University of Manchester, Manchester, United Kingdom (R.B.W.); the Icahn School of Medicine at Mount Sinai, New York (M.L.); the SKiN Centre for Dermatology, Probity Medical Research, Peterborough, and Queen's University, Kingston, ON (M.G.), and Dalhousie University, Halifax, NS (R.G.L.) - all in Canada; Yale University, New Haven, and Central Connecticut Dermatology Research, Cromwell - both in Connecticut (B.S.); Paul Sabatier University, Toulouse, France (C.P.); UCB Pharma, Brussels (D.D.C., V.V.); UCB Pharma, Raleigh, NC (C.M., C.C., L.P.); and the Oregon Medical Research Center, Portland (A.B.)., Lebwohl M; From the Center for Translational Research in Inflammatory Skin Diseases, University Medical Center Hamburg-Eppendorf, Hamburg, Germany (K.R.); the Dermatology Centre, Salford Royal NHS Foundation Trust, Manchester NIHR Biomedical Research Centre, University of Manchester, Manchester, United Kingdom (R.B.W.); the Icahn School of Medicine at Mount Sinai, New York (M.L.); the SKiN Centre for Dermatology, Probity Medical Research, Peterborough, and Queen's University, Kingston, ON (M.G.), and Dalhousie University, Halifax, NS (R.G.L.) - all in Canada; Yale University, New Haven, and Central Connecticut Dermatology Research, Cromwell - both in Connecticut (B.S.); Paul Sabatier University, Toulouse, France (C.P.); UCB Pharma, Brussels (D.D.C., V.V.); UCB Pharma, Raleigh, NC (C.M., C.C., L.P.); and the Oregon Medical Research Center, Portland (A.B.)., Gooderham M; From the Center for Translational Research in Inflammatory Skin Diseases, University Medical Center Hamburg-Eppendorf, Hamburg, Germany (K.R.); the Dermatology Centre, Salford Royal NHS Foundation Trust, Manchester NIHR Biomedical Research Centre, University of Manchester, Manchester, United Kingdom (R.B.W.); the Icahn School of Medicine at Mount Sinai, New York (M.L.); the SKiN Centre for Dermatology, Probity Medical Research, Peterborough, and Queen's University, Kingston, ON (M.G.), and Dalhousie University, Halifax, NS (R.G.L.) - all in Canada; Yale University, New Haven, and Central Connecticut Dermatology Research, Cromwell - both in Connecticut (B.S.); Paul Sabatier University, Toulouse, France (C.P.); UCB Pharma, Brussels (D.D.C., V.V.); UCB Pharma, Raleigh, NC (C.M., C.C., L.P.); and the Oregon Medical Research Center, Portland (A.B.)., Strober B; From the Center for Translational Research in Inflammatory Skin Diseases, University Medical Center Hamburg-Eppendorf, Hamburg, Germany (K.R.); the Dermatology Centre, Salford Royal NHS Foundation Trust, Manchester NIHR Biomedical Research Centre, University of Manchester, Manchester, United Kingdom (R.B.W.); the Icahn School of Medicine at Mount Sinai, New York (M.L.); the SKiN Centre for Dermatology, Probity Medical Research, Peterborough, and Queen's University, Kingston, ON (M.G.), and Dalhousie University, Halifax, NS (R.G.L.) - all in Canada; Yale University, New Haven, and Central Connecticut Dermatology Research, Cromwell - both in Connecticut (B.S.); Paul Sabatier University, Toulouse, France (C.P.); UCB Pharma, Brussels (D.D.C., V.V.); UCB Pharma, Raleigh, NC (C.M., C.C., L.P.); and the Oregon Medical Research Center, Portland (A.B.)., Langley RG; From the Center for Translational Research in Inflammatory Skin Diseases, University Medical Center Hamburg-Eppendorf, Hamburg, Germany (K.R.); the Dermatology Centre, Salford Royal NHS Foundation Trust, Manchester NIHR Biomedical Research Centre, University of Manchester, Manchester, United Kingdom (R.B.W.); the Icahn School of Medicine at Mount Sinai, New York (M.L.); the SKiN Centre for Dermatology, Probity Medical Research, Peterborough, and Queen's University, Kingston, ON (M.G.), and Dalhousie University, Halifax, NS (R.G.L.) - all in Canada; Yale University, New Haven, and Central Connecticut Dermatology Research, Cromwell - both in Connecticut (B.S.); Paul Sabatier University, Toulouse, France (C.P.); UCB Pharma, Brussels (D.D.C., V.V.); UCB Pharma, Raleigh, NC (C.M., C.C., L.P.); and the Oregon Medical Research Center, Portland (A.B.)., Paul C; From the Center for Translational Research in Inflammatory Skin Diseases, University Medical Center Hamburg-Eppendorf, Hamburg, Germany (K.R.); the Dermatology Centre, Salford Royal NHS Foundation Trust, Manchester NIHR Biomedical Research Centre, University of Manchester, Manchester, United Kingdom (R.B.W.); the Icahn School of Medicine at Mount Sinai, New York (M.L.); the SKiN Centre for Dermatology, Probity Medical Research, Peterborough, and Queen's University, Kingston, ON (M.G.), and Dalhousie University, Halifax, NS (R.G.L.) - all in Canada; Yale University, New Haven, and Central Connecticut Dermatology Research, Cromwell - both in Connecticut (B.S.); Paul Sabatier University, Toulouse, France (C.P.); UCB Pharma, Brussels (D.D.C., V.V.); UCB Pharma, Raleigh, NC (C.M., C.C., L.P.); and the Oregon Medical Research Center, Portland (A.B.)., De Cuyper D; From the Center for Translational Research in Inflammatory Skin Diseases, University Medical Center Hamburg-Eppendorf, Hamburg, Germany (K.R.); the Dermatology Centre, Salford Royal NHS Foundation Trust, Manchester NIHR Biomedical Research Centre, University of Manchester, Manchester, United Kingdom (R.B.W.); the Icahn School of Medicine at Mount Sinai, New York (M.L.); the SKiN Centre for Dermatology, Probity Medical Research, Peterborough, and Queen's University, Kingston, ON (M.G.), and Dalhousie University, Halifax, NS (R.G.L.) - all in Canada; Yale University, New Haven, and Central Connecticut Dermatology Research, Cromwell - both in Connecticut (B.S.); Paul Sabatier University, Toulouse, France (C.P.); UCB Pharma, Brussels (D.D.C., V.V.); UCB Pharma, Raleigh, NC (C.M., C.C., L.P.); and the Oregon Medical Research Center, Portland (A.B.)., Vanvoorden V; From the Center for Translational Research in Inflammatory Skin Diseases, University Medical Center Hamburg-Eppendorf, Hamburg, Germany (K.R.); the Dermatology Centre, Salford Royal NHS Foundation Trust, Manchester NIHR Biomedical Research Centre, University of Manchester, Manchester, United Kingdom (R.B.W.); the Icahn School of Medicine at Mount Sinai, New York (M.L.); the SKiN Centre for Dermatology, Probity Medical Research, Peterborough, and Queen's University, Kingston, ON (M.G.), and Dalhousie University, Halifax, NS (R.G.L.) - all in Canada; Yale University, New Haven, and Central Connecticut Dermatology Research, Cromwell - both in Connecticut (B.S.); Paul Sabatier University, Toulouse, France (C.P.); UCB Pharma, Brussels (D.D.C., V.V.); UCB Pharma, Raleigh, NC (C.M., C.C., L.P.); and the Oregon Medical Research Center, Portland (A.B.)., Madden C; From the Center for Translational Research in Inflammatory Skin Diseases, University Medical Center Hamburg-Eppendorf, Hamburg, Germany (K.R.); the Dermatology Centre, Salford Royal NHS Foundation Trust, Manchester NIHR Biomedical Research Centre, University of Manchester, Manchester, United Kingdom (R.B.W.); the Icahn School of Medicine at Mount Sinai, New York (M.L.); the SKiN Centre for Dermatology, Probity Medical Research, Peterborough, and Queen's University, Kingston, ON (M.G.), and Dalhousie University, Halifax, NS (R.G.L.) - all in Canada; Yale University, New Haven, and Central Connecticut Dermatology Research, Cromwell - both in Connecticut (B.S.); Paul Sabatier University, Toulouse, France (C.P.); UCB Pharma, Brussels (D.D.C., V.V.); UCB Pharma, Raleigh, NC (C.M., C.C., L.P.); and the Oregon Medical Research Center, Portland (A.B.)., Cioffi C; From the Center for Translational Research in Inflammatory Skin Diseases, University Medical Center Hamburg-Eppendorf, Hamburg, Germany (K.R.); the Dermatology Centre, Salford Royal NHS Foundation Trust, Manchester NIHR Biomedical Research Centre, University of Manchester, Manchester, United Kingdom (R.B.W.); the Icahn School of Medicine at Mount Sinai, New York (M.L.); the SKiN Centre for Dermatology, Probity Medical Research, Peterborough, and Queen's University, Kingston, ON (M.G.), and Dalhousie University, Halifax, NS (R.G.L.) - all in Canada; Yale University, New Haven, and Central Connecticut Dermatology Research, Cromwell - both in Connecticut (B.S.); Paul Sabatier University, Toulouse, France (C.P.); UCB Pharma, Brussels (D.D.C., V.V.); UCB Pharma, Raleigh, NC (C.M., C.C., L.P.); and the Oregon Medical Research Center, Portland (A.B.)., Peterson L; From the Center for Translational Research in Inflammatory Skin Diseases, University Medical Center Hamburg-Eppendorf, Hamburg, Germany (K.R.); the Dermatology Centre, Salford Royal NHS Foundation Trust, Manchester NIHR Biomedical Research Centre, University of Manchester, Manchester, United Kingdom (R.B.W.); the Icahn School of Medicine at Mount Sinai, New York (M.L.); the SKiN Centre for Dermatology, Probity Medical Research, Peterborough, and Queen's University, Kingston, ON (M.G.), and Dalhousie University, Halifax, NS (R.G.L.) - all in Canada; Yale University, New Haven, and Central Connecticut Dermatology Research, Cromwell - both in Connecticut (B.S.); Paul Sabatier University, Toulouse, France (C.P.); UCB Pharma, Brussels (D.D.C., V.V.); UCB Pharma, Raleigh, NC (C.M., C.C., L.P.); and the Oregon Medical Research Center, Portland (A.B.)., Blauvelt A; From the Center for Translational Research in Inflammatory Skin Diseases, University Medical Center Hamburg-Eppendorf, Hamburg, Germany (K.R.); the Dermatology Centre, Salford Royal NHS Foundation Trust, Manchester NIHR Biomedical Research Centre, University of Manchester, Manchester, United Kingdom (R.B.W.); the Icahn School of Medicine at Mount Sinai, New York (M.L.); the SKiN Centre for Dermatology, Probity Medical Research, Peterborough, and Queen's University, Kingston, ON (M.G.), and Dalhousie University, Halifax, NS (R.G.L.) - all in Canada; Yale University, New Haven, and Central Connecticut Dermatology Research, Cromwell - both in Connecticut (B.S.); Paul Sabatier University, Toulouse, France (C.P.); UCB Pharma, Brussels (D.D.C., V.V.); UCB Pharma, Raleigh, NC (C.M., C.C., L.P.); and the Oregon Medical Research Center, Portland (A.B.).
Publikováno v:
The New England journal of medicine [N Engl J Med] 2021 Jul 08; Vol. 385 (2), pp. 142-152. Date of Electronic Publication: 2021 Apr 23.